Summit Therapeutics Inc
NASDAQ:SMMT

Watchlist Manager
Summit Therapeutics Inc Logo
Summit Therapeutics Inc
NASDAQ:SMMT
Watchlist
Price: 26.2 USD -5.18% Market Closed
Market Cap: 19.5B USD

Wall Street
Price Targets

SMMT Price Targets Summary
Summit Therapeutics Inc

Wall Street analysts forecast SMMT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SMMT is 34.78 USD with a low forecast of 12.12 USD and a high forecast of 46.2 USD.

Lowest
Price Target
12.12 USD
54% Downside
Average
Price Target
34.78 USD
33% Upside
Highest
Price Target
46.2 USD
76% Upside
Summit Therapeutics Inc Competitors:
Price Targets
ACLX
Arcellx Inc
69% Upside
OCX
OncoCyte Corp
75% Upside
300841
Chengdu Kanghua Biological Products Co Ltd
11% Upside
FYB
Formycon AG
89% Upside
688336
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
15% Downside
DVYSR
Devyser Diagnostics AB
28% Upside
GLPG
Galapagos NV
12% Upside
BAVA
Bavarian Nordic A/S
54% Upside

Revenue
Forecast

Revenue Estimate
Summit Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Summit Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Summit Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SMMT's stock price target?
Price Target
34.78 USD

According to Wall Street analysts, the average 1-year price target for SMMT is 34.78 USD with a low forecast of 12.12 USD and a high forecast of 46.2 USD.

Back to Top